Metabolic Stack

This stack pairs AOD-9604, a modified fragment of human growth hormone, with Retatrutide, a triple agonist targeting the GIP, GLP-1, and glucagon receptors, for researchers investigating metabolic and body composition pathways together. AOD-9604 has been studied for its lipolytic properties, specifically its influence on fat metabolism without the broader growth-promoting effects associated with full-length growth hormone. Retatrutide has been investigated for its combined receptor activity across three distinct metabolic pathways, with research examining its role in glucose regulation, appetite signalling, and energy expenditure. Combined, this stack is of interest in metabolic research exploring complementary mechanisms of lipid and glucose regulation. Each vial is supplied alongside bacteriostatic water for laboratory reconstitution.